Dapagliflozin vs Nivolumab

## Dapagliflozin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Dapagliflozin** and **Nivolumab**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Dapagliflozin — 12.9 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Dapagliflozin — C21H25ClO6; Nivolumab — N/A.

**Molecular Weight**: Dapagliflozin — 408.8730 g/mol; Nivolumab — N/A.

**Type**: Dapagliflozin — Small molecule; Nivolumab — Antibody.